Impact of Timing on the Efficacy of Omeprazole/Sodium Bicarbonate [Zegerid] 40mg in Healing Reflux Esophagitis.

Trial Profile

Impact of Timing on the Efficacy of Omeprazole/Sodium Bicarbonate [Zegerid] 40mg in Healing Reflux Esophagitis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Nov 2015

At a glance

  • Drugs Omeprazole/sodium bicarbonate (Primary)
  • Indications Reflux oesophagitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jun 2011 Status changed from recruiting to completed, according to ClinicalTrials.gov.
    • 10 May 2011 Results presented at Digestive Disease Week 2011.
    • 20 Oct 2010 To date, 88 of the planed 100 patients have been enrolled, according to an ACG abstract.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top